No advantage of Aβ 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

بواسطة Szekely, C.A., Green, R.C., Breitner, J.C.S., Østbye, T., Beiser, A.S., Corrada, M.M., Dodge, H.H., Ganguli, M., Kawas, C.H., Kuller, L.H., Psaty, B.M., Resnick, S.M., Wolf, P.A., Zonderman, A.B., Welsh-Bohmer, K.A., Zandi, P.P.
منشور في 2014